<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">43320</article-id><article-id pub-id-type="doi">10.7554/eLife.43320</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-45360"><name><surname>Shang</surname><given-names>Jinsai</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8164-1544</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45354"><name><surname>Brust</surname><given-names>Richard</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9200-1101</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101614"><name><surname>Mosure</surname><given-names>Sarah A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101615"><name><surname>Bass</surname><given-names>Jared</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-126354"><name><surname>Munoz-Tello</surname><given-names>Paola</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101610"><name><surname>Lin</surname><given-names>Hua</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101611"><name><surname>Hughes</surname><given-names>Travis S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5764-5884</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101612"><name><surname>Tang</surname><given-names>Miru</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101613"><name><surname>Ge</surname><given-names>Qingfeng</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-124948"><name><surname>Kamekencka</surname><given-names>Theodore M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-9739"><name><surname>Kojetin</surname><given-names>Douglas J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8058-6168</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Integrative Structural and Computational Biology</institution>, <institution>The Scripps Research Institute</institution>, <addr-line><named-content content-type="city">Jupiter</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Molecular Medicine</institution>, <institution>The Scripps Research Institute</institution>, <addr-line><named-content content-type="city">Jupiter</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Center for Biomolecular Structure and Dynamics</institution>, <institution>University of Montana</institution>, <addr-line><named-content content-type="city">Missoula</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Chemistry and Biochemistry</institution>, <institution>Southern Illinois University</institution>, <addr-line><named-content content-type="city">Carbondale</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1018"><name><surname>Kuriyan</surname><given-names>John</given-names></name><role>Reviewing editor</role><aff><institution>University of California, Berkeley</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>dkojetin@scripps.edu</email> (DK);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>12</month><year>2018</year></pub-date><volume>7</volume><elocation-id>e43320</elocation-id><history><date date-type="received"><day>03</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>18</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Shang et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Shang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-43320-v1.pdf"/><abstract><p>Crystal structures of peroxisome proliferator-activated receptor gamma (PPARγ) have revealed overlapping binding modes for synthetic and natural/endogenous ligands, indicating competition for the orthosteric pocket. Here we show that cobinding of a synthetic ligand to the orthosteric pocket can push natural and endogenous PPARγ ligands (fatty acids) out of the orthosteric pocket towards an alternate ligand-binding site near the functionally important omega (Ω) loop. X-ray crystallography, NMR spectroscopy, all-atom molecular dynamics simulations, and mutagenesis coupled to quantitative biochemical functional and cellular assays reveal that synthetic ligand and fatty acid cobinding can form a 'ligand link' to the Ω loop and synergistically affect the structure and function of PPARγ. These findings contribute to a growing body of evidence indicating ligand binding to nuclear receptors can be more complex than the classical one-for-one orthosteric exchange of a natural or endogenous ligand with a synthetic ligand.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK101871</award-id><principal-award-recipient><name><surname>Kojetin</surname><given-names>Douglas J</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>16- POST27780018</award-id><principal-award-recipient><name><surname>Brust</surname><given-names>Richard</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>1659594</award-id><principal-award-recipient><name><surname>Mosure</surname><given-names>Sarah A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>The Scripps Research Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Mosure</surname><given-names>Sarah A</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R00DK103116</award-id><principal-award-recipient><name><surname>Hughes</surname><given-names>Travis S</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>F32DK108442</award-id><principal-award-recipient><name><surname>Brust</surname><given-names>Richard</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Crystal structures and diffraction data have been deposited in the PDB under accession codes 5UGM, 6AVI, 6AUG, 6MCZ, 6MD0, 6MD1, 6MD2, and 6MD4.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shang J</collab><collab>Kojetin DJ</collab></person-group><year iso-8601-date="2017">2017</year><source>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Edaglitazone</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/5UGM">http://www.rcsb.org/structure/5UGM</ext-link><comment>Protein Data Bank, 5UGM</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shang J</collab><collab>Kojetin DJ</collab></person-group><year iso-8601-date="2017">2017</year><source>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Nonanoic acid</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6AVI">http://www.rcsb.org/structure/6AVI</ext-link><comment>Protein Data Bank, 6AVI</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shang J</collab><collab>Kojetin DJ</collab></person-group><year iso-8601-date="2017">2017</year><source>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with SR16832</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6AUG">http://www.rcsb.org/structure/6AUG</ext-link><comment>Protein Data Bank, 6AUG</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shang J</collab><collab>Kojetin DJ</collab></person-group><year iso-8601-date="2018">2018</year><source>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Arachidonic Acid</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6MCZ">http://www.rcsb.org/structure/6MCZ</ext-link><comment>Protein Data Bank, 6MCZ</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shang J</collab><collab>Kojetin DJ</collab></person-group><year iso-8601-date="2018">2018</year><source>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Oleic Acid</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6MD0">http://www.rcsb.org/structure/6MD0</ext-link><comment>Protein Data Bank, 6MD0</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shang J</collab><collab>Kojetin DJ</collab></person-group><year iso-8601-date="2018">2018</year><source>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Oleic acid</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6MD1">http://www.rcsb.org/structure/6MD1</ext-link><comment>Protein Data Bank, 6MD1</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shang J</collab><collab>Kojetin DJ</collab></person-group><year iso-8601-date="2018">2018</year><source>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Arachidonic acid</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6MD2">http://www.rcsb.org/structure/6MD2</ext-link><comment>Protein Data Bank, 6MD2</comment></element-citation><element-citation id="dataset8" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shang J</collab><collab>Kojetin DJ</collab></person-group><year iso-8601-date="2018">2018</year><source>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Rosiglitazone and Oleic acid</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6MD4">http://www.rcsb.org/structure/6MD4</ext-link><comment>Protein Data Bank, 6MD4</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset9" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Kojetin D</collab><collab>Johnson B</collab></person-group><year iso-8601-date="2012">2012</year><source>PPARgamma LBD complexed with rosiglitazone</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.13018/BMR17975">https://doi.org/10.13018/BMR17975</ext-link><comment>Biological Magnetic Resonance Bank, 17975</comment></element-citation><element-citation id="dataset10" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Liberato MV</collab><collab>Nascimento AS</collab><collab>Polikarpov I</collab></person-group><year iso-8601-date="2012">2012</year><source>Human PPAR gamma in complex with nonanoic acids</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/4EM9">https://www.rcsb.org/structure/4EM9</ext-link><comment>Protein Data Bank, 4EM9</comment></element-citation><element-citation id="dataset11" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Liberato MV</collab><collab>Nascimento AS</collab><collab>Polikarpov I</collab></person-group><year iso-8601-date="2012">2012</year><source>Human peroxisome proliferator-activated receptor gamma in complex with rosiglitazone</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/4EMA">https://www.rcsb.org/structure/4EMA</ext-link><comment>Protein Data Bank, 4EMA</comment></element-citation><element-citation id="dataset12" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wang Z</collab></person-group><year iso-8601-date="2009">2009</year><source>Crystal Structure of PPARg in complex with T2384</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/3K8S">https://www.rcsb.org/structure/3K8S</ext-link><comment>Protein Data Bank, 3K8S</comment></element-citation><element-citation id="dataset13" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Nolte RT</collab><collab>Wisely GB</collab><collab>Milburn MV</collab></person-group><year iso-8601-date="1998">1998</year><source>LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/2PRG">https://www.rcsb.org/structure/2PRG</ext-link><comment>Protein Data Bank, 2PRG</comment></element-citation><element-citation id="dataset14" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Gampe Jr RT</collab><collab>Montana VG</collab><collab>Lambert MH</collab><collab>Miller AB</collab><collab>Bledsoe RK</collab><collab>Milburn MV</collab><collab>Kliewer SA</collab><collab>Willson TM</collab><collab>Xu HE</collab></person-group><year iso-8601-date="2000">2000</year><source>THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/1FM6">https://www.rcsb.org/structure/1FM6</ext-link><comment>Protein Data Bank, 1FM6</comment></element-citation><element-citation id="dataset15" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Tomioka D</collab><collab>Hashimoto H</collab><collab>Sato M</collab><collab>Shimizu T</collab></person-group><year iso-8601-date="2011">2011</year><source>Human PPAR gamma ligand binding domain in complex with MCC555</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/3B0Q">https://www.rcsb.org/structure/3B0Q</ext-link><comment>Protein Data Bank, 3B0Q</comment></element-citation><element-citation id="dataset16" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Rajagopalan S</collab><collab>Webb P</collab><collab>Baxter JD</collab><collab>Brennan RG</collab><collab>Phillips KJ</collab></person-group><year iso-8601-date="2011">2011</year><source>Crystal structure of PPAR gamma ligand binding domain in complex with a novel partial agonist GQ-16</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/3T03">https://www.rcsb.org/structure/3T03</ext-link><comment>Protein Data Bank, 3T03</comment></element-citation><element-citation id="dataset17" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Bruning JB</collab><collab>Nettles KW</collab></person-group><year iso-8601-date="2007">2007</year><source>Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/2Q61">https://www.rcsb.org/structure/2Q61</ext-link><comment>Protein Data Bank, 2Q61</comment></element-citation><element-citation id="dataset18" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Tomioka D</collab><collab>Hashimoto H</collab><collab>Sato M</collab><collab>Shimizu T</collab></person-group><year iso-8601-date="2011">2011</year><source>Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/3B0R">https://www.rcsb.org/structure/3B0R</ext-link><comment>Protein Data Bank, 3B0R</comment></element-citation><element-citation id="dataset19" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Nolte RT</collab><collab>Wisely GB</collab><collab>Milburn MV</collab></person-group><year iso-8601-date="1998">1998</year><source>LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/1PRG">https://www.rcsb.org/structure/1PRG</ext-link><comment>Protein Data Bank, 1PRG</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-43320-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>